Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.

Mitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L.

Glob Heart. 2019 Sep;14(3):215-240. doi: 10.1016/j.gheart.2019.07.009. No abstract available.

PMID:
31451236
2.

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.

Vallejo-Vaz AJ, Ray KK, Ginsberg HN, Davidson MH, Eckel RH, Lee LV, Bessac L, Pordy R, Letierce A, Cannon CP.

Atherosclerosis. 2019 Sep;288:85-93. doi: 10.1016/j.atherosclerosis.2019.07.008. Epub 2019 Jul 12.

3.

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10. Review.

4.

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.

Ray KK, Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Louie MJ, Bujas-Bobanovic M, Minini P, Eckel RH, Cannon CP.

Atherosclerosis. 2019 Sep;288:194-202. doi: 10.1016/j.atherosclerosis.2019.06.896. Epub 2019 Jun 8.

5.

Response by Ward et al to Letter Regarding Article, "Statin Toxicity: Mechanistic Insights and Clinical Implications".

Ward NC, Watts GF, Eckel RH.

Circ Res. 2019 Jun 7;124(12):e121-e122. doi: 10.1161/CIRCRESAHA.119.315233. Epub 2019 Jun 6. No abstract available.

PMID:
31170055
6.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

7.

Physical Activity Improves Lipid and Weight-Loss Outcomes After Metabolic Bariatric Surgery in Adolescents with Severe Obesity.

Price PH, Kaizer AM, Daniels SR, Jenkins TM, Inge TH, Eckel RH.

Obesity (Silver Spring). 2019 Jun;27(6):989-996. doi: 10.1002/oby.22475. Epub 2019 May 3.

PMID:
31050388
8.

The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.

Chait A, Eckel RH.

Ann Intern Med. 2019 May 7;170(9):626-634. doi: 10.7326/M19-0203. Epub 2019 Apr 30.

PMID:
31035285
9.

Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program.

Shavadia JS, Sharma A, Gu X, Neaton J, DeLeve L, Holmes D, Home P, Eckel RH, Watkins PB, Granger CB.

Clin Trials. 2019 Jun;16(3):253-262. doi: 10.1177/1740774519836766. Epub 2019 Mar 18.

PMID:
30880443
10.

Reconsidering the Importance of the Association of Egg Consumption and Dietary Cholesterol With Cardiovascular Disease Risk.

Eckel RH.

JAMA. 2019 Mar 19;321(11):1055-1056. doi: 10.1001/jama.2019.1850. No abstract available.

PMID:
30874737
11.

Cardiometabolic Medicine: A Call for a New Subspeciality Training Track in Internal Medicine.

Eckel RH, Blaha MJ.

Am J Med. 2019 Jul;132(7):788-790. doi: 10.1016/j.amjmed.2019.02.027. Epub 2019 Mar 12. No abstract available.

PMID:
30871919
12.

Ad libitum Weekend Recovery Sleep Fails to Prevent Metabolic Dysregulation during a Repeating Pattern of Insufficient Sleep and Weekend Recovery Sleep.

Depner CM, Melanson EL, Eckel RH, Snell-Bergeon JK, Perreault L, Bergman BC, Higgins JA, Guerin MK, Stothard ER, Morton SJ, Wright KP Jr.

Curr Biol. 2019 Mar 18;29(6):957-967.e4. doi: 10.1016/j.cub.2019.01.069. Epub 2019 Feb 28.

PMID:
30827911
13.

Reduction in FSH Throughout the Menstrual Cycle After Omega-3 Fatty Acid Supplementation in Young Normal Weight but not Obese Women.

Bauer JL, Kuhn K, Bradford AP, Al-Safi ZA, Harris MA, Eckel RH, Robledo CY, Malkhasyan A, Johnson J, Gee NR, Polotsky AJ.

Reprod Sci. 2019 Aug;26(8):1025-1033. doi: 10.1177/1933719119828099. Epub 2019 Feb 17.

PMID:
30773100
14.

Statin Toxicity.

Ward NC, Watts GF, Eckel RH.

Circ Res. 2019 Jan 18;124(2):328-350. doi: 10.1161/CIRCRESAHA.118.312782.

PMID:
30653440
15.

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.

Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Eckel RH, Cannon CP, Lee LV, Bessac L, Pordy R, Letierce A, Ray KK.

J Am Heart Assoc. 2018 Sep 18;7(18):e009221. doi: 10.1161/JAHA.118.009221.

16.

Do current guidelines for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America.

Kabakambira JD, Baker RL Jr, Briker SM, Courville AB, Mabundo LS, DuBose CW, Chung ST, Eckel RH, Sumner AE.

BMJ Glob Health. 2018 Oct 15;3(5):e001057. doi: 10.1136/bmjgh-2018-001057. eCollection 2018.

17.

Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.

Basu D, Huggins LA, Scerbo D, Obunike J, Mullick AE, Rothenberg PL, Di Prospero NA, Eckel RH, Goldberg IJ.

Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2207-2216. doi: 10.1161/ATVBAHA.118.311339.

18.

Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Bjornstad P, Eckel RH.

Curr Diab Rep. 2018 Oct 17;18(12):127. doi: 10.1007/s11892-018-1101-6. Review.

PMID:
30328521
19.

Sex differences in lipid and lipoprotein metabolism.

Palmisano BT, Zhu L, Eckel RH, Stafford JM.

Mol Metab. 2018 Sep;15:45-55. doi: 10.1016/j.molmet.2018.05.008. Epub 2018 May 16. Review.

20.

Global status of diabetes prevention and prospects for action: A consensus statement.

Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G, Hill JO, Kumwenda M, Leslie RD, Olson DE, Pozzilli P, Weber SL, Umpierrez GE.

Diabetes Metab Res Rev. 2018 Sep;34(6):e3021. doi: 10.1002/dmrr.3021. Epub 2018 Jun 8. Review.

PMID:
29757486
21.

Lipoprotein Lipase Is a Feature of Alternatively-Activated Microglia and May Facilitate Lipid Uptake in the CNS During Demyelination.

Bruce KD, Gorkhali S, Given K, Coates AM, Boyle KE, Macklin WB, Eckel RH.

Front Mol Neurosci. 2018 Mar 15;11:57. doi: 10.3389/fnmol.2018.00057. eCollection 2018.

22.

Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.

Lim S, Eckel RH, Koh KK.

Atherosclerosis. 2018 May;272:33-40. doi: 10.1016/j.atherosclerosis.2018.03.013. Epub 2018 Mar 8. Review.

PMID:
29547706
23.

Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort.

Millstein RJ, Pyle LL, Bergman BC, Eckel RH, Maahs DM, Rewers MJ, Schauer IE, Snell-Bergeon JK.

J Diabetes Complications. 2018 Apr;32(4):418-423. doi: 10.1016/j.jdiacomp.2018.01.002. Epub 2018 Jan 10.

24.

Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.

Saxon DR, Rasouli N, Eckel RH.

Drugs. 2018 Feb;78(2):203-214. doi: 10.1007/s40265-017-0857-3. Review.

PMID:
29305768
25.

Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.

Gadek KE, Wang H, Hall MN, Sungello M, Libby A, MacLaskey D, Eckel RH, Olwin BB.

PLoS One. 2018 Jan 5;13(1):e0190963. doi: 10.1371/journal.pone.0190963. eCollection 2018.

26.

Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humans.

Bergman BC, Perreault L, Strauss A, Bacon S, Kerege A, Harrison K, Brozinick JT, Hunerdosse DM, Playdon MC, Holmes W, Bui HH, Sanders P, Siddall P, Wei T, Thomas MK, Kuo MS, Eckel RH.

Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E152-E164. doi: 10.1152/ajpendo.00142.2017. Epub 2017 Oct 3.

27.

Lipoprotein Lipase Maintains Microglial Innate Immunity in Obesity.

Gao Y, Vidal-Itriago A, Kalsbeek MJ, Layritz C, García-Cáceres C, Tom RZ, Eichmann TO, Vaz FM, Houtkooper RH, van der Wel N, Verhoeven AJ, Yan J, Kalsbeek A, Eckel RH, Hofmann SM, Yi CX.

Cell Rep. 2017 Sep 26;20(13):3034-3042. doi: 10.1016/j.celrep.2017.09.008.

28.

Disruption of Lipid Uptake in Astroglia Exacerbates Diet-Induced Obesity.

Gao Y, Layritz C, Legutko B, Eichmann TO, Laperrousaz E, Moullé VS, Cruciani-Guglielmacci C, Magnan C, Luquet S, Woods SC, Eckel RH, Yi CX, Garcia-Caceres C, Tschöp MH.

Diabetes. 2017 Oct;66(10):2555-2563. doi: 10.2337/db16-1278. Epub 2017 Jul 14.

29.

Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting.

Seggelke SA, Lindsay MC, Hazlett I, Sanagorski R, Eckel RH, Low Wang CC.

Curr Diab Rep. 2017 Aug;17(8):64. doi: 10.1007/s11892-017-0884-1. Review.

PMID:
28699089
30.

The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance.

Alman AC, Smith SR, Eckel RH, Hokanson JE, Burkhardt BR, Sudini PR, Wu Y, Schauer IE, Pereira RI, Snell-Bergeon JK.

Obesity (Silver Spring). 2017 Jul;25(7):1284-1291. doi: 10.1002/oby.21875. Epub 2017 May 30.

31.

Lipoprotein lipase in hypothalamus is a key regulator of body weight gain and glucose homeostasis in mice.

Laperrousaz E, Moullé VS, Denis RG, Kassis N, Berland C, Colsch B, Fioramonti X, Philippe E, Lacombe A, Vanacker C, Butin N, Bruce KD, Wang H, Wang Y, Gao Y, Garcia-Caceres C, Prévot V, Tschöp MH, Eckel RH, Le Stunff H, Luquet S, Magnan C, Cruciani-Guglielmacci C.

Diabetologia. 2017 Jul;60(7):1314-1324. doi: 10.1007/s00125-017-4282-7. Epub 2017 Apr 29.

PMID:
28456865
32.

Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism.

Bruce KD, Zsombok A, Eckel RH.

Front Endocrinol (Lausanne). 2017 Apr 4;8:60. doi: 10.3389/fendo.2017.00060. eCollection 2017. Review.

33.

Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins.

Yu T, Sungelo MJ, Goldberg IJ, Wang H, Eckel RH.

Horm Metab Res. 2017 May;49(5):400-406. doi: 10.1055/s-0042-110934. Epub 2017 Apr 10.

PMID:
28395380
34.

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy.

Crawford ED, Schally AV, Pinthus JH, Block NL, Rick FG, Garnick MB, Eckel RH, Keane TE, Shore ND, Dahdal DN, Beveridge TJR, Marshall DC.

Urol Oncol. 2017 May;35(5):183-191. doi: 10.1016/j.urolonc.2017.01.025. Epub 2017 Mar 18. Review.

35.

Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.

Taha DA, Zgair A, Lee JB, de Moor CH, Barrett DA, Bruce KD, Sungelo M, Eckel RH, Gershkovich P.

Eur J Pharm Sci. 2017 Mar 30;100:163-175. doi: 10.1016/j.ejps.2017.01.018. Epub 2017 Jan 16.

PMID:
28104473
36.

Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Patel SS, Truong U, King M, Ferland A, Moreau KL, Dorosz J, Hokanson JE, Wang H, Kinney GL, Maahs DM, Eckel RH, Nadeau KJ, Cree-Green M.

Vasc Med. 2017 Apr;22(2):85-95. doi: 10.1177/1358863X16682107. Epub 2017 Jan 17.

37.

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, Groop PH, Handelsman Y, Insel RA, Mathieu C, McElvaine AT, Palmer JP, Pugliese A, Schatz DA, Sosenko JM, Wilding JP, Ratner RE.

Diabetes. 2017 Feb;66(2):241-255. doi: 10.2337/db16-0806. Epub 2016 Dec 15. Review.

38.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Obes Surg. 2017 Jan;27(1):2-21. doi: 10.1007/s11695-016-2457-9.

PMID:
27957699
39.

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.

Ray KK, Ginsberg HN, Davidson MH, Pordy R, Bessac L, Minini P, Eckel RH, Cannon CP.

Circulation. 2016 Dec 13;134(24):1931-1943. Epub 2016 Oct 24.

40.

Nutrition Interventions for Cardiovascular Disease.

de Jesus JM, Kahan S, Eckel RH.

Med Clin North Am. 2016 Nov;100(6):1251-1264. doi: 10.1016/j.mcna.2016.06.007. Review.

PMID:
27745593
41.

Sex differences in obesity development in pair-fed neuronal lipoprotein lipase deficient mice.

Wang H, Wang Y, Taussig MD, Eckel RH.

Mol Metab. 2016 May 31;5(10):1025-1032. doi: 10.1016/j.molmet.2016.05.013. eCollection 2016 Oct.

42.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Surg Obes Relat Dis. 2016 Jul;12(6):1144-62. doi: 10.1016/j.soard.2016.05.018.

PMID:
27568469
43.

Statin Intolerance: A Literature Review and Management Strategies.

Saxon DR, Eckel RH.

Prog Cardiovasc Dis. 2016 Sep - Oct;59(2):153-164. doi: 10.1016/j.pcad.2016.07.009. Epub 2016 Aug 3. Review.

PMID:
27497504
44.

No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.

Colhoun HM, Ginsberg HN, Robinson JG, Leiter LA, Müller-Wieland D, Henry RR, Cariou B, Baccara-Dinet MT, Pordy R, Merlet L, Eckel RH.

Eur Heart J. 2016 Oct 14;37(39):2981-2989. Epub 2016 Jul 26.

45.

Obesity development in neuron-specific lipoprotein lipase deficient mice is not responsive to increased dietary fat content or change in fat composition.

Wang H, Taussig MD, DiPatrizio NV, Bruce K, Piomelli D, Eckel RH.

Metabolism. 2016 Jul;65(7):987-97. doi: 10.1016/j.metabol.2016.01.015. Epub 2016 Feb 4.

PMID:
27282869
46.

Treatment of Obesity: Weight Loss and Bariatric Surgery.

Wolfe BM, Kvach E, Eckel RH.

Circ Res. 2016 May 27;118(11):1844-55. doi: 10.1161/CIRCRESAHA.116.307591. Review.

47.

Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Adams TD, Arterburn DE, Nathan DM, Eckel RH.

Diabetes Care. 2016 Jun;39(6):912-23. doi: 10.2337/dc16-0157. Review.

48.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Diabetes Care. 2016 Jun;39(6):861-77. doi: 10.2337/dc16-0236.

PMID:
27222544
49.

Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes.

Jarvie JL, Wang H, Kinney GL, Snell-Bergeon J, Hokanson JE, Eckel RH.

J Clin Lipidol. 2016 May-Jun;10(3):577-86. doi: 10.1016/j.jacl.2016.01.001. Epub 2016 Jan 30.

PMID:
27206945
50.

Proactive and Progressive Approaches in Managing Obesity.

Eckel RH, Bays HE, Klein S, Bade Horn D.

Postgrad Med. 2016 Oct;128 Suppl 1:21-30. doi: 10.1080/00325481.2016.1181412. Epub 2016 May 6.

PMID:
27153316

Supplemental Content

Loading ...
Support Center